A detailed history of Squarepoint Ops LLC transactions in Argenx Se stock. As of the latest transaction made, Squarepoint Ops LLC holds 18,400 shares of ARGX stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,400
Previous 41,492 55.65%
Holding current value
$11.5 Million
Previous $17.8 Million 44.07%
% of portfolio
0.02%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$434.22 - $551.9 $10 Million - $12.7 Million
-23,092 Reduced 55.65%
18,400 $9.98 Million
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $4.85 Million - $6.15 Million
13,618 Added 48.86%
41,492 $17.8 Million
Q1 2024

May 15, 2024

BUY
$356.95 - $413.29 $3.38 Million - $3.92 Million
9,474 Added 51.49%
27,874 $11 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $5.93 Million - $8.85 Million
17,492 Added 1926.43%
18,400 $7 Million
Q2 2023

Aug 14, 2023

SELL
$360.14 - $422.58 $1.11 Million - $1.3 Million
-3,082 Reduced 77.24%
908 $353,000
Q1 2023

May 15, 2023

BUY
$334.23 - $403.65 $1.33 Million - $1.61 Million
3,990 New
3,990 $1.49 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $3.98 Million - $4.59 Million
11,589 Added 638.16%
13,405 $4.73 Million
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $489,557 - $688,046
1,816 New
1,816 $688,000
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $1.19 Million - $1.64 Million
-4,667 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $211,079 - $273,951
776 Added 19.94%
4,667 $1.63 Million
Q3 2021

Nov 15, 2021

BUY
$295.0 - $350.58 $1.15 Million - $1.36 Million
3,891 New
3,891 $1.18 Million
Q2 2021

Aug 16, 2021

SELL
$257.11 - $319.92 $467,168 - $581,294
-1,817 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$268.3 - $380.31 $487,501 - $691,023
1,817 New
1,817 $500,000
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $202,170 - $248,897
-1,758 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$98.85 - $134.59 $173,778 - $236,609
1,758 New
1,758 $219,000
Q4 2018

Feb 14, 2019

SELL
$63.81 - $109.82 $240,882 - $414,570
-3,775 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$75.5 - $96.63 $285,012 - $364,778
3,775 New
3,775 $286,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.